PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia
· Delayed Price · Currency is IDR 160.00
+2.00 (1.27%)
Jun 5, 2025, 3:49 PM WIB
IDX:DGNS Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 158,523 | 163,072 | 145,696 | 192,886 | 302,182 | 183,171 | Upgrade
|
| Revenue Growth (YoY) | 5.82% | 11.93% | -24.46% | -36.17% | 64.97% | 256.80% | Upgrade
|
| Cost of Revenue | 89,971 | 90,998 | 86,384 | 99,127 | 153,626 | 97,692 | Upgrade
|
| Gross Profit | 68,552 | 72,074 | 59,312 | 93,759 | 148,555 | 85,479 | Upgrade
|
| Selling, General & Admin | 69,021 | 70,113 | 73,420 | 78,320 | 67,127 | 18,493 | Upgrade
|
| Other Operating Expenses | -478.75 | 36.37 | 1,043 | -1,660 | - | - | Upgrade
|
| Operating Expenses | 68,543 | 70,150 | 74,463 | 76,660 | 67,127 | 18,493 | Upgrade
|
| Operating Income | 9.48 | 1,924 | -15,151 | 17,099 | 81,429 | 66,986 | Upgrade
|
| Interest Expense | -866.59 | -881.83 | -475.24 | -628.02 | -331.52 | - | Upgrade
|
| Interest & Investment Income | 84.89 | 107.37 | 392.24 | 862.94 | 2,217 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -35.1 | -10.59 | Upgrade
|
| EBT Excluding Unusual Items | -772.22 | 1,150 | -15,234 | 17,333 | 83,279 | 66,975 | Upgrade
|
| Gain (Loss) on Sale of Assets | -307.17 | -285.77 | 1,661 | - | - | - | Upgrade
|
| Pretax Income | -1,079 | 863.76 | -13,573 | 17,333 | 83,279 | 66,975 | Upgrade
|
| Income Tax Expense | 116.32 | 116.32 | 83 | 4,669 | 18,975 | 14,289 | Upgrade
|
| Net Income | -1,196 | 747.44 | -13,656 | 12,665 | 64,304 | 52,687 | Upgrade
|
| Net Income to Common | -1,196 | 747.44 | -13,656 | 12,665 | 64,304 | 52,687 | Upgrade
|
| Net Income Growth | - | - | - | -80.31% | 22.05% | 468.07% | Upgrade
|
| Shares Outstanding (Basic) | 1,250 | 1,250 | 1,250 | 1,250 | 1,240 | 1,000 | Upgrade
|
| Shares Outstanding (Diluted) | 1,250 | 1,250 | 1,250 | 1,250 | 1,240 | 1,000 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.78% | 24.04% | 232.91% | Upgrade
|
| EPS (Basic) | -0.96 | 0.60 | -10.92 | 10.13 | 51.84 | 52.69 | Upgrade
|
| EPS (Diluted) | -0.96 | 0.60 | -10.92 | 10.00 | 51.84 | 52.69 | Upgrade
|
| EPS Growth | - | - | - | -80.71% | -1.60% | 70.64% | Upgrade
|
| Free Cash Flow | -15,608 | -16,095 | -25,141 | -40,052 | -8,966 | 20,365 | Upgrade
|
| Free Cash Flow Per Share | -12.49 | -12.88 | -20.11 | -32.04 | -7.23 | 20.36 | Upgrade
|
| Gross Margin | 43.24% | 44.20% | 40.71% | 48.61% | 49.16% | 46.67% | Upgrade
|
| Operating Margin | 0.01% | 1.18% | -10.40% | 8.87% | 26.95% | 36.57% | Upgrade
|
| Profit Margin | -0.75% | 0.46% | -9.37% | 6.57% | 21.28% | 28.76% | Upgrade
|
| Free Cash Flow Margin | -9.85% | -9.87% | -17.26% | -20.77% | -2.97% | 11.12% | Upgrade
|
| EBITDA | 12,118 | 13,960 | -3,604 | 26,494 | 86,244 | 69,392 | Upgrade
|
| EBITDA Margin | 7.64% | 8.56% | -2.47% | 13.74% | 28.54% | 37.88% | Upgrade
|
| D&A For EBITDA | 12,109 | 12,036 | 11,547 | 9,396 | 4,815 | 2,406 | Upgrade
|
| EBIT | 9.48 | 1,924 | -15,151 | 17,099 | 81,429 | 66,986 | Upgrade
|
| EBIT Margin | 0.01% | 1.18% | -10.40% | 8.87% | 26.95% | 36.57% | Upgrade
|
| Effective Tax Rate | - | 13.47% | - | 26.93% | 22.79% | 21.33% | Upgrade
|
| Advertising Expenses | - | 6,579 | 6,159 | 7,007 | 5,078 | 1,882 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.